The IDM has curated a go-to range of reliable information to guide and assist staff and students during this time of crisis. We are continuously updating the various COVID-19 resources listed on our webpage below.
The IDM - a cross-faculty, multidisciplinary postgraduate health research institute
Based on the UCT Faculty of Health Sciences campus in a 7,100 sqm state-of-the-art facility, we operate in the fields of infectious diseases and molecular medicine.
Clinical research relevant to the needs of Africa's people
The IDM influences health policy and practice by translating our scientific discoveries and applying them in various communities; community relationships and trust are critical.
Capacity building in the IDM
The largest research entity at UCT, the IDM is a national leader in research and health sciences human capital development.
IDM driving world class research
We conduct research at the laboratory-clinic-community interface by engaging a wide range of scientific and clinical disciplines; with 62 consortia linking us with 183 institutions in 22 African countries and 24 countries beyond.
University accredited research institute - Tackling diseases of importance in Africa - Developing people - Impacting health policy and practice
A team of young videographers participating in Eh!woza’s unique blend of biomedical research workshops and skills development through media training have focused their lenses on the impact of COVID-19 in Khayelitsha, which has one of the highest tuberculosis (TB) rates in the world.
News last week that AIDS-related deaths in South Africa are on a downward trajectory since the early 2000s is a victory for the country and proves that antiretroviral (ARV) treatment is powerful and effective, said the University of Cape Town’s (UCT) Professor Linda-Gail Bekker.
“A burgeoning epidemic of drug-resistant tuberculosis (TB) threatens to derail global control efforts [of the disease],” and countries like South Africa must shift gear to actively search out drug-sensitive and drug-resistant cases, renowned researcher Professor Keertan Dheda wrote in a recent paper published in the leading medical journal Nature Medicine.